Expression of the activaiion antigen CD27 in rheumatoid arthritis

Clinical Immunology and Immunopathology

Volumn 80, Issue 2, 1996, Pages 129-138

  Tak, Paul P ^a   Hintzen, Rogier Q ^a   Teunissen, Jaap J M ^a   Smeets, Tom J M ^a   Daha, Mohamed R ^a   Van Lier, René A W ^c   Kluin, Philip M ^b   Meinders, A Edo ^a   Swaak, Anton J G ^c   Breedveld, Ferdinand C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; RHEUMATOID FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTE MIGRATION; MALE; OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; AGED; BIOSYNTHESIS; BLOOD; IMMUNOLOGY; KNEE; METABOLISM; MIDDLE AGED; PATHOLOGY; SOLUBILITY; SYNOVIAL FLUID;

ADULT; AGED; ANTIGENS, CD27; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; RHEUMATOID FACTOR; SOLUBILITY; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; T-LYMPHOCYTES;

EID: 0030215476     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0106     Document Type: Article

References (43)

1. 1. Panayi, G. S., Lanchbury, J. S., and Kingsley, G. H., The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum. 35, 729-735, 1992.
2. 2. Terry, L. A., Brown, M. H., and Beverley, P. C., The monoclonal antibody, UCHL1, recognizes a 180,000 MW component of the human leucocyte-common antigen, CD45. Immunology 64, 331-336, 1988.
3. 3. Akbar, A. N., Terry, L., Timms, A., Beverley, P. C., and Janossy, G., Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J. Immunol. 140, 2171-2178, 1988.
4. 4. Behr, C., Human naive and memory T cells: How far have we come? Bull. Inst. Pasteur 91, 65-74, 1993.
5. 5. Potocnik, A. J., Kinne, R., Menninger, H., Zacher, J., Emmrich, F., and Kroczek, R. A., Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand. J. Immunol. 310, 213-224, 1990.
6. 6. Hanly, J. G., Pledger, D., Parkhill, W., Roberts, M., and Gross, M., Phenotypic characteristics of dissociated mononuclear cells from rheumatoid synovial membrane. J. Rheumatol. 17, 1274-1279, 1990.
7. 7. Pitzalis, C., Kingsley, G. H., Murphy, J., and Panayi, G. S., Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint. Clin. Immunol. Immunopathol. 45, 252-258, 1987.
8. 8. Cush, J. J., Pietschmann, P., Oppenheimer Marks, N., and Lipsky, P. E., The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium. Arthritis Rheum. 35, 1434-1444, 1992.
9. 9. Iannone, F., Corrigall, V. M., Kingsley, G. H., and Panayi, G. S., Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis. Eur. J. Immunol. 24, 2706-2713, 1994.
10. + lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur. J. Immunol. 22, 993-999, 1992.
11. + T helper subsets. J. Immunol. 149, 2795-2802, 1992.
12. 12. Hintzen, R. Q., De Jong, R., Lens, S. M. A., Brouwer, M., Baars, P., and Van Lier, R. A. W., Regulation of CD27 expression on subsets of mature T-lymphocytes. J. Immunol. 151, 2426-2435, 1993.
13. 13. Camerini, D., Walz, G., Loenen, W. A. M., Borst, J., and Seed, B., The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immunol. 147, 3165-3169, 1991.
14. 14. Hintzen, R. Q., De Jong, R., Lens, S. M. A., and Van Lier, R. A. W., CD27: marker and mediator of T-cell activation? Immunol. Today 15, 307-309, 1994.
15. 15. Bigler, R. D., Bushkin, Y., and Chiorazzi, N., S152 (CD27). A modulating disulfide-linked T cell activation antigen. J. Immunol. 141, 21-28, 1988.
16. 16. Van Lier, R. A., Borst, J., Vroom, T. M., Klein, H., Van Mourik, P., Zeijlemaker, W. P., and Melief, C. J., Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J. Immunol. 139, 1589-1596, 1987.
17. + T cell subset. Eur. J. Immunol. 18, 811-816, 1988.
18. 18. Lens, S. M. A., De Jong, R., Hooibrink, B., Schuurman, J., Pals, S. T., Hintzen, R. Q., Van Oers, M. H. J., and Van Lier, R. A. W., CD70, a marker of recently in vivo primed B cells. Submitted for publication.
19. 19. Elson, L. H., Shaw, S., Van Lier, R. A. W., and Nutman, T. B., T cell subpopulation phenotypes in filarial infections: CD27 negativity defines a population greatly enriched for Th2 cells. Int. Immunol. 6, 1003-1009, 1994.
20. 20. Yazdanbakhsh, M., Sartono, E., Kruize, Y. C. M., Kurniawan, A., Van der Pouw-Kraan, T., Van der Meide, P. H., Selkirk, M. E., Partono, F., Hintzen, R. Q., Van Lier, R. A. W., and Maizels, R. M., Elevated levels of T cell activation antigen CD27 and increased interleukin-4 production in human lymphatic filariasis. Eur. J. Immunol. 23, 3312-3317, 1993.
21. 21. Hintzen, R. Q., Van Lier, R. A., Kuijpers, K. C., Baars, P. A., Schaasberg, W., Lucas, C. J., and Polman, C. H., Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 35, 211-217, 1991.
22. 22. Chamuleau, M. E., ten Berge, I. J., Schellekens, P. T., Wilmink, J. M., Hintzen, R. Q., and Van Lier, R. A., Serum levels of soluble CD27 in renal transplant recipients. Transplantation 54, 932-936, 1992.
23. 23. Hol, B. E. A., Hintzen, R. Q., Van Lier, R. A. W., Alberts, C., Out, T. A., and Jansen, H. M., Soluble and cellular markers of T cell activation in patients with pulmonary sarcoidosis. Am. Rev. Respir. Dis. 148, 643-649, 1993.
24. 24. Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315-324, 1988.
25. 25. Altman, R., Asch, E. S., Bloch, D. A., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T. D., Greenwald, R., Hochberg, M., Howell, D., Kaplan, D., Koopman, W., Longley, S., Mankin, H., McShane, D. J., Medsger, T., Meenan, R., Mikkelsen, W., Moskowitz, R., Murphey, W., Rothschild, B., Segal, M., Sokoloff, L., and Wolfe, F., Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum. 29, 1039-1049, 1986.
26. 26. Otten, H. G., Daha, M. R., de Rooij, H. H., and Breedveld, F. C., Quantitative detection of class-specific rheumatoid factors using mouse monoclonal antibodies and the biotin/streptavidin enhancement system. Br. J. Rheumatol. 28, 310-316, 1989.
27. 27. Hintzen, R. Q., De Jong, R., Hack, C. E., Chamuleau, M., de Vries, E. F., ten Berge, I. J., Borst, J., and Van Lier, R. A., A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J. Immunol. 147, 29-35, 1991.
28. 28. Borst, J., Sluyser, C., De Vries, E., Klein, H., Melief, C. J. M., and Van Lier, R. A. W., Alternative molecular form of human T cell-specific antigen CD27 expressed upon T cell activation. Eur. J. Immunol. 19, 357-364, 1989.
29. 29. Parker, R. H., and Pearson, C. M., A simplified synovial biopsy needle. Arthritis Rheum. 6, 172-176, 1963.
30. 30. Tak, P. P., Van der Lubbe, P. A., Cauli, A., Daha, M. R., Smeets, T. J. M., Kluin, P. M., Meinders, A. E., Yanni, G., Panayi, G. S., and Breedveld, F. C., Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum. 38, 1457-1465, 1995.
31. 31. Tak, P. P., Kummer, J. A., Hack, C. E., Daha, M. R., Smeets, T. J. M., Erkelens, G. W., Meinders, A. E., Kluin, P. M., and Breedveld, F. C., Granzyme positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum. 37, 1735-1743, 1994.
32. 32. Loenen, W. A. M., De Vries, E., Gravestein, L. A., Hintzen, R. Q., Van Lier, R. A. W., and Borst, J., The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis. Eur. J. Immunol. 22, 447-455, 1992.
33. 33. Firestein, G. S., and Zvaifler, N. J., How important are T cells in chronic rheumatoid synovitis. Arthritis Rheum. 33, 768-773, 1990.
34. 34. Myers, S. L., Brandt, K. D., Ehlich, J. W., Braunstein, E. M., Shelbourne, K. D., Heck, D. A., and Kalasinski, L. A., Synovial inflammation in patients with early osteoarthritis of the knee. J. Rheumatol. 17, 1662-1669, 1990.
35. 35. Koch, A. E., Robinson, P. G., Radosevich, J. A., and Pope, R. M., Distribution of CD45RA and CD45RO T-lymphocyte subsets in rheumatoid arthritis synovial tissue. J. Clin. Immunol. 10, 192-199, 1990.
36. 36. Kurosaka, M., and Ziff, M., Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J. Exp. Med. 158, 1191-1210, 1983.
37. + T cell population. J. Immunol. 154, 17-25, 1995.
38. 38. Hintzen, R. Q., Lens, S. M. A., Koopman, G., Pals, S. T., Spits, H., and Van Lier, R. A. W., CD70 represents the human ligand for CD27. Int. Immunol. 6, 477-480, 1994.
39. 39. Bowman, M. R., Crimmins, M. A. V., Yetz-Aldape, J., Kriz, R., Kelleher, K., and Herrmann, S., The cloning of CD70 and its identification as the ligand for CD27. J. Immunol. 152, 1756-1761, 1994.
40. 40. Agematsu, K., Kobata, T., Yang, F. C., Nakazawa, T., Fukushima, K., Kitahara, M., Mori, T., Sugita, K., Morimoto, C., and Komiyama, A., CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur. J. Immunol. 25, 2825-2829, 1995.
41. 41. Yanni, G., Whelan, A., Feighery, C., and Bresnihan, B., Analysis of cell populations in rheumatoid arthritis synovial tissues. Semin. Arthritis Rheum. 21, 393-399, 1992.
42. 42. Otten, H. G., Dolhain, R. J., de Rooij, H. H., and Breedveld, F. C., Rheumatoid factor production by mononuclear cells derived from different sites of patients with rheumatoid arthritis. Clin. Exp. Immunol. 94, 236-240, 1993.
43. 43. Hintzen, R. Q., Fiszer, U., Frederikson, S., Rep, M., Polman, C. H., Van Lier, R. A., and Link, H., Analysis of CD27 surface expression on T-cell subsets in MS patients and control individuals. J. Neuroimmunol. 56, 99-105, 1995.